BCL2 and lymphoma: Our cohort includes 3 patients with variant 3’MYC loss and 1 patient with 5’MYC poly-signaling; all the patients in our cohort with variant MYC signaling had concurrent BCL2 rearrangements, raising the possibility of whether these were “double-hit” lymphoma.